SEC
GH icon

Seven Eight Capital’s Guardant Health GH Stock Holding History

Seven Eight Capital’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-66,307
Closed -$1.52M – 250
2024
Q3 		$1.52M Buy
+66,307
New +$1.88M 0.14% 263
2024
Q1 		– Sell
-13,464
Closed -$364K – 691
2023
Q4 		$364K Sell
13,464
-72,345
-84% -$1.9M 0.04% 489
2023
Q3 		$2.54M Buy
85,809
+6,193
+8% +$218K 0.3% 81
2023
Q2 		$2.85M Buy
79,616
+59,490
+296% +$1.71M 0.47% 54
2023
Q1 		$472K Sell
20,126
-65,354
-76% -$1.87M 0.1% 253
2022
Q4 		$2.33M Buy
+85,480
New +$3.91M 0.61% 39
2021
Q3 		– Sell
-10,282
Closed -$1.28M – 621
2021
Q2 		$1.28M Sell
10,282
-5,575
-35% -$750K 0.18% 201
2021
Q1 		$2.04M Hold
15,857
– – 0.47% 61
2020
Q4 		$2.04M Buy
+15,857
New +$1.82M 0.46% 61
2019
Q4 		– Sell
-48,142
Closed -$3.07M – 682
2019
Q3 		$3.07M Buy
+48,142
New +$4.24M 0.16% 188
2019
Q2 		– Sell
-16,383
Closed -$1.26M – 636
2019
Q1 		$1.26M Buy
+16,383
New +$908K 0.07% 326

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Seven Eight Capital's GH Position: Q4 2024 in Review

Seven Eight Capital sold out of Guardant Health (GH) in Q4 2024, closing a stake of 66,307 shares — an estimated $1.52M sold.

Seven Eight Capital first reported a position in GH in Q1 2019 and held it in 11 quarters. The position peaked at $3.07M in Q3 2019. 297 funds tracked by Wall St. Rank hold GH as of Q4 2024.

  • Seven Eight Capital reported no remaining Guardant Health position as of Q4 2024 after selling out during the quarter.
  • Seven Eight Capital sold 66,307 Guardant Health shares in Q4 2024, an estimated $1.52M.
  • Seven Eight Capital first reported a position in Guardant Health in Q1 2019 and held it in 11 quarters.
  • Seven Eight Capital's Guardant Health position peaked at $3.07M in Q3 2019.
  • 297 funds tracked by Wall St. Rank held Guardant Health as of Q4 2024.

Based on Seven Eight Capital's 13F filing for Q4 2024.